The effect of concealed concomitant anal incontinence symptoms in patients with urinary incontinence on their quality of life.

International Urogynecology Journal
Selcuk SelcukAtes Karateke

Abstract

We evaluated the bother of concomitant anal incontinence (AI) in women with urinary incontinence (UI) who do not primarily report their anal symptoms. This prospective study assessed patients with complaings of primary UI without initially reporting anal symptoms. After urogynecological assessment, all patients were asked to complete the validated versions of the Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Pelvic Floor and Incontinence Sexual Impact Questionnaire (PISQ-12), Wexner Incontinence Scale (WIS) score, and Beck Anxiety Inventory (BAI). Patients who scored nil in the WIS constituted the group of only UI, and patients with scores ≥1 were grouped as double incontinence (DI)., and the groups were compared. Among 136 women, 69.1 % (94) had only UI, whereas 30.9 % (42) had DI. There were no differences in age, parity, body mass index (BMI), and prolapse status between patients with UI and those with DI, except menopausal status. Women with DI scored worse for IIQ-7, PISQ-12, and BAI questionnaires compared with women with UI. This difference was not statistically significant for IIQ-7 only. Our data show that concealed AI symptoms may contribute to the anxiety of the patient and even al...Continue Reading

References

Jan 1, 1993·Diseases of the Colon and Rectum·J M Jorge, S D Wexner
Oct 6, 1997·British Journal of Obstetrics and Gynaecology·A H Sultan, M A Kamm
Oct 27, 1998·Diseases of the Colon and Rectum·R NelsonV Jesudason
May 25, 1999·Neurourology and Urodynamics·D GordonM P David
Mar 23, 2001·American Journal of Obstetrics and Gynecology·R G RogersC Qualls
May 26, 2001·International Urogynecology Journal and Pelvic Floor Dysfunction·D L FaltinA Weil
Jan 25, 2002·International Urogynecology Journal and Pelvic Floor Dysfunction·G R RogersC Qualls
Oct 18, 2002·Obstetrics and Gynecology·Michele MeschiaFabio Amicarelli
Sep 5, 2003·International Urogynecology Journal and Pelvic Floor Dysfunction·Rebecca G RogersClifford Qualls
Sep 23, 2003·Current Opinion in Obstetrics & Gynecology·Gloria Lacima, Miguel Pera
Dec 4, 2003·The British Journal of Surgery·K DavisJ Bland
Feb 25, 2005·International Urogynecology Journal and Pelvic Floor Dysfunction·Dharmesh S KapoorAbdul H Sultan
Jul 14, 2005·Gastroenterology·Adil E BharuchaL Joseph Melton
Nov 9, 2006·Depression and Anxiety·Eric R HenningRichard G Heimberg
Jul 4, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Cetin CamAtes Karateke
Jun 10, 2011·International Urogynecology Journal·Cetin CamAtes Karateke

❮ Previous
Next ❯

Citations

Feb 25, 2014·International Urogynecology Journal·Leonardo Robson Pinheiro Sobreira BezerraKathiane Lustosa Augusto
May 9, 2014·International Urogynecology Journal·Sara B CichowskiRebecca G Rogers
Mar 18, 2015·Women's Health·Isuzu Meyer, Holly E Richter
Mar 10, 2015·International Urogynecology Journal·Deepa Gopinath, Swati Jha
Jun 19, 2016·Women and Birth : Journal of the Australian College of Midwives·Julie TuckerVicki L Clifton
Nov 16, 2016·International Urogynecology Journal·Heidi Wendell BrownMeg E Wise
Sep 19, 2017·Scandinavian Journal of Gastroenterology·Carlos Cerdán SantacruzJavier Cerdán Miguel
Mar 6, 2016·Female Pelvic Medicine & Reconstructive Surgery·Mehmet KucukbasCetin Cam
May 17, 2019·Diseases of the Colon and Rectum·Isuzu MeyerHolly E Richter
Apr 20, 2021·Nursing Standard·Julie TuckerAnnette Briley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.